Noble Financial Initiates Coverage on Nutriband (NASDAQ:NTRB)

Stock analysts at Noble Financial initiated coverage on shares of Nutriband (NASDAQ:NTRB) in a research note issued to investors on Wednesday, MarketBeat Ratings reports. The brokerage set an “outperform” rating and a $13.00 price target on the stock. Noble Financial’s target price would suggest a potential upside of 31.31% from the stock’s current price.

Nutriband Stock Performance

NASDAQ NTRB opened at $9.90 on Wednesday. The firm’s fifty day moving average price is $4.49 and its two-hundred day moving average price is $5.41. Nutriband has a 1 year low of $2.22 and a 1 year high of $11.78. The firm has a market capitalization of $109.99 million, a P/E ratio of -13.94 and a beta of 0.99. The company has a current ratio of 4.96, a quick ratio of 4.83 and a debt-to-equity ratio of 0.01.

Nutriband (NASDAQ:NTRB) last issued its earnings results on Tuesday, December 3rd. The company reported ($0.12) earnings per share (EPS) for the quarter. Nutriband had a negative net margin of 338.51% and a negative return on equity of 54.49%.

About Nutriband

Nutriband Inc develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy.